视频

Jintiange Capsule Alleviates Rheumatoid Arthritis and Reverses Changes of Serum Metabolic Profile in Collagen-Induced Arthritic Rats

 

Authors Wang X, Shen Y, Zhuang X, Wang N, Zhang Q, Zhu L, Liu Y, Lu X, Qin L, Zhang Q

Received 7 September 2021

Accepted for publication 22 November 2021

Published 8 December 2021 Volume 2021:14 Pages 6685—6706

DOI https://doi.org/10.2147/JIR.S338107

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Professor Ning Quan

Purpose: Jintiange capsule (JTG), an approved drug developed as a substitute for tiger bone (TB), has been clinically applied for osteoporosis therapy since 2003. The drug is composed of bionic TB powder, in which peptides and proteins are primarily enriched from other bone extracts. However, as a precious material of traditional Chinese medicine (TCM), TB has been mainly understood and used in TCM to relieve osteoporosis, rheumatoid arthritis and bone injury. Inspired by those, the purpose of this study was to investigate whether JTG also had an effect on relieving rheumatoid arthritis in collagen-induced arthritic (CIA) rats and explore potential mechanism from the perspective of serum metabolic profile changes.
Methods: JTG was analyzed using Nano LC-MS/MS and orally administered in CIA rats for 6 weeks. After administration, intervention effects of JTG on synovial inflammation, bone micro-architecture and bone metabolism were studied, and the impact of JTG on serum metabolic profiles in CIA rats was investigated by metabolomics.
Results: Nine bioactive peptides were identified in JTG. In animal treatments, JTG alleviated paw swelling (< 0.01), arthritic severity (< 0.01) and synovial tissue proliferation, as well as inflammatory cell infiltration of ankle joint, decreased bone loss, improved microstructure of bone in CIA rats by regulating bone absorption and formation, specifically increasing bone mineral density (BMD) (< 0.05), bone volume fraction (BVF) (< 0.05), trabecular number (Tb.N) (< 0.05) and decreasing trabecular separation (Tb.Sp) (< 0.05). Besides, serum IL-6 was down-regulated remarkably in CIA rats (< 0.05). Furthermore, metabolomics analysis revealed that 32 metabolites were regulated significantly (< 0.05) by comparison between CIA model and JTG in 360 mg/kg dose. The pathway analysis implied that JTG was involved in regulation of biosynthesis of phenylalanine.
Conclusion: JTG alleviates rheumatoid arthritis and reverses changes in serum metabolic profile in CIA rats.
Keywords: bionic tiger bone powder, synovial inflammation, bone micro-architecture, bone metabolism, metabolomics